๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Population pharmacokinetics of halofantrine in healthy volunteers and patients with symptomatic falciparum malaria

โœ Scribed by Kerenaftali Klein; Leon Aarons; Feiko O. ter Kuile; Francois Nosten; Nick J. White; Michael D. Edstein; Paktiya Teja-Isavadharm

Book ID
119876933
Publisher
Pharmaceutical Press
Year
2012
Tongue
English
Weight
884 KB
Volume
64
Category
Article
ISSN
2042-7158

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Pharmacokinetics of an extended-dose hal
Pharmacokinetics of an extended-dose halofantrine regimen in patients with malaria and in healthy volunteers*
โœ Ohrt, Colin; Watt, George; Teja-Isavadharm, Paktiya; Keeratithakul, Duangsuda; L ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› Nature Publishing Group ๐ŸŒ English โš– 811 KB

The pharmacokinetics and tolerance of a 4.5 gm 7&y halofantrine loading dose regimen were evaluated in 10 Thai patients with malaria and in 10 noninfected volunteers. Halofantrine peak plasma concentrations and bioavailability on the first day of treatment were significantly lower in patients with m

Pharmacokinetics of halofantrine and n-d
Pharmacokinetics of halofantrine and n-desbutylhalofantrine in patients with falciparum malaria following a multiple dose regimen of halofantrine
โœ J. R. Veenendaal; A. D. Parkinson; N. Kere; K. H. Rieckmann; M. D. Edstein ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› Springer ๐ŸŒ English โš– 430 KB

Halofantrine is a new blood schizontocidal drug used for the treatment of multidrug-resistant falciparum malaria. The pharmacokinetics of halofantrine (HAL) and its principal metabolite, N-desbutylhalofantrine (BHAL), was investigated in 6 adult male patients of Melanesian origin with uncomplicated